• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600

    5/7/26 6:01:00 PM ET
    $APLS
    $BFAM
    $BIIB
    $RELY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Other Consumer Services
    Consumer Discretionary
    Get the next $APLS alert in real time by email

    NEW YORK, May 7, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 effective prior to the opening of trading on Thursday, May 14:

    • Bright Horizons Family Solutions Inc. (NYSE:BFAM) will replace Tri Pointe Homes Inc. (NYSE:TPH). Sumitomo Forestry Group (TSE: 1911) is acquiring Tri Pointe Homes in a deal expected to close soon, pending final closing conditions.
    • Remitly Global Inc. (NASD: RELY) will replace Apellis Pharmaceuticals Inc. (NASD: APLS). S&P 500 constituent Biogen Inc. (NASD: BIIB) is acquiring Apellis Pharmaceuticals in a deal expected to close soon, pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name      

    Action

    Company Name

    Ticker

    GICS Sector

    May 14, 2026

    S&P SmallCap 600

    Addition

    Bright Horizons Family Solutions

    BFAM

    Consumer Discretionary

    May 14, 2026

    S&P SmallCap 600

    Deletion

    Tri Pointe Homes

    TPH

    Consumer Discretionary

    May 14, 2026

    S&P SmallCap 600

    Addition

    Remitly Global

    RELY

    Financials

    May 14, 2026

    S&P SmallCap 600

    Deletion

    Apellis Pharmaceuticals

    APLS

    Health Care

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/.

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    index_services@spglobal.com

    Media Inquiries

    spdji.comms@spglobal.com

    Cision View original content:https://www.prnewswire.com/news-releases/bright-horizons-family-solutions-and-remitly-global-set-to-join-sp-smallcap-600-302766326.html

    SOURCE S&P Dow Jones Indices

    Get the next $APLS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APLS
    $BFAM
    $BIIB
    $RELY

    CompanyDatePrice TargetRatingAnalyst
    Biogen Inc.
    $BIIB
    7/13/2026$235.00Hold → Buy
    Truist
    Biogen Inc.
    $BIIB
    6/8/2026$255.00Hold → Buy
    Needham
    Biogen Inc.
    $BIIB
    5/15/2026Outperform
    Evercore ISI
    Remitly Global Inc.
    $RELY
    5/7/2026$30.00 → $33.00Buy
    Monness Crespi & Hardt
    Biogen Inc.
    $BIIB
    4/22/2026$225.00Neutral → Buy
    UBS
    Biogen Inc.
    $BIIB
    4/20/2026$250.00Equal Weight → Overweight
    Wells Fargo
    Biogen Inc.
    $BIIB
    4/14/2026$214.00Neutral → Overweight
    Piper Sandler
    Apellis Pharmaceuticals Inc.
    $APLS
    3/13/2026$31.00Buy
    Roth Capital
    More analyst ratings

    $APLS
    $BFAM
    $BIIB
    $RELY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Business Officer Sharma Pankaj sold $375,450 worth of shares (15,000 units at $25.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 752,810 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    7/17/26 7:22:58 PM ET
    $RELY
    Real Estate

    Director Hug Joshua sold $17,234,576 worth of shares (687,768 units at $25.06) as part of a pre-agreed trading plan, decreasing direct ownership by 20% to 2,680,889 units (SEC Form 4)

    4 - Remitly Global, Inc. (0001782170) (Issuer)

    7/17/26 7:21:40 PM ET
    $RELY
    Real Estate

    New insider Thomas Darren Robert claimed ownership of 6,174 shares (SEC Form 3)

    3 - S&P Global Inc. (0000064040) (Issuer)

    7/9/26 4:05:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Remitly to Report Second Quarter Financial Results on August 5, 2026

    SEATTLE, July 22, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company"), a trusted provider of financial services that transcend borders, today announced that it will report second quarter financial results after the market closes on Wednesday, August 5, 2026. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Second Quarter Financial Results Conference Call and Webcast Information:When: Wednesday, August 5th, 20

    7/22/26 4:05:00 PM ET
    $RELY
    Real Estate

    S&P Dow Jones Indices and Pantera Capital Launch New Index for Digital Assets

    The S&P Pantera Digital Asset Index brings credibility and structure to digital asset indexing by focusing on quality and real utilityNEW YORK, July 21, 2026 /PRNewswire/ -- S&P Dow Jones Indices, the world's leading index provider, and Pantera Capital, a leading digital asset-native investment firm, have launched the S&P Pantera Digital Asset Index, designed to serve as a benchmark for institutional investors who want to allocate to digital assets in a more disciplined and structured way. Unlike many existing crypto indexes that focus on price momentum or popular tokens (including meme coins or Bitcoin), this new index uses a rules-based approach similar to what's used in traditional financ

    7/21/26 1:15:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Global Launches Adaptive Retrieval, Giving Customers a New Way to Access Data Across AI and Agentic Workflows

    With this launch, S&P Global becomes the first to offer customers two complementary ways to retrieve data, Deterministic and Adaptive, giving AI systems reliable access to trusted S&P Global data across a full spectrum of workflows, from tightly controlled pipelines to autonomous, multi-agent systems.Both retrieval methods will be offered together as part of a single solution called the S&P Global AI Data Portal. NEW YORK, July 21, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the launch of Adaptive Retrieval, a new service that allows customer AI agents and large language models (LLMs) to access and assemble licensed S&P Global data using natural language queries. Alongside th

    7/21/26 11:18:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Moritz Robert Edward Jr. bought $500,001 worth of shares (1,152 units at $434.03) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:19:22 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    CEO, S&P Dow Jones Indices Clay Catherine R bought $1,078,475 worth of shares (2,500 units at $431.39) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:18:28 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    CEO & President Cheung Martina bought $998,297 worth of shares (2,322 units at $429.93), increasing direct ownership by 9% to 27,518 units (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/1/26 4:07:01 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Biogen upgraded by Truist with a new price target

    Truist upgraded Biogen from Hold to Buy and set a new price target of $235.00

    7/13/26 8:58:02 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Biogen upgraded by Needham with a new price target

    Needham upgraded Biogen from Hold to Buy and set a new price target of $255.00

    6/8/26 8:21:53 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Evercore ISI resumed coverage on Biogen

    Evercore ISI resumed coverage of Biogen with a rating of Outperform

    5/15/26 8:16:23 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLS
    $BFAM
    $BIIB
    $RELY
    SEC Filings

    View All

    SEC Form 144 filed by Remitly Global Inc.

    144 - Remitly Global, Inc. (0001782170) (Subject)

    7/16/26 4:34:11 PM ET
    $RELY
    Real Estate

    Amendment: SEC Form SCHEDULE 13G/A filed by Remitly Global Inc.

    SCHEDULE 13G/A - Remitly Global, Inc. (0001782170) (Subject)

    7/8/26 10:11:21 AM ET
    $RELY
    Real Estate

    S&P Global Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - S&P Global Inc. (0000064040) (Filer)

    7/6/26 4:10:29 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZURZUVAE issued to BIOGEN INC

    Submission status for BIOGEN INC's drug ZURZUVAE (SUPPL-3) with active ingredient ZURANOLONE has changed to 'Approval' on 04/20/2026. Application Category: NDA, Application Number: 217369, Application Classification: Labeling

    4/23/26 6:14:48 PM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (ORIG-1) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/12/2024. Application Category: NDA, Application Number: 761347, Application Classification: Type 3 - New Dosage Form

    9/16/24 6:52:10 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for VUMERITY issued to BIOGEN INC

    Submission status for BIOGEN INC's drug VUMERITY (SUPPL-17) with active ingredient DIROXIMEL FUMARATE has changed to 'Approval' on 09/11/2024. Application Category: NDA, Application Number: 211855, Application Classification: Manufacturing (CMC)

    9/16/24 6:24:32 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLS
    $BFAM
    $BIIB
    $RELY
    Leadership Updates

    Live Leadership Updates

    View All

    Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

    NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600:  S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions.  V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect

    7/20/26 5:42:00 PM ET
    $KRYS
    $AVNS
    $BRK.A
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Specialties
    Finance: Consumer Services

    Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600

    NEW YORK, July 16, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent Molina Healthcare Inc. (NYSE: MOH) will replace National Storage Affiliates Trust (NYSE:NSA) in the S&P MidCap 400, and Construction Partners Inc. (NASD: ROAD) will replace Molina Healthcare in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 22. S&P 500 constituent Public Storage (NYSE:PSA) is acquiring National Storage Affiliates Trust in a deal that is expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGI

    7/16/26 5:56:00 PM ET
    $ROAD
    $MOH
    $NSA
    Military/Government/Technical
    Industrials
    Medical Specialities
    Health Care

    Biogen Appoints Michael J. Parini as Chief Legal Officer

    CAMBRIDGE, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (NASDAQ:BIIB) today announced the appointment of Michael J. Parini as Chief Legal Officer, effective August 3, 2026. Parini will serve as a member of Biogen's Executive Committee and report to Christopher A. Viehbacher, President and Chief Executive Officer. In this role, Mr. Parini will have responsibility for oversight of Biogen’s global legal and compliance functions. "Michael brings to Biogen a rare combination of deep legal and industry expertise as well as broad operational leadership that will further contribute to Biogen’s next chapter of renewed growth," said Christopher A. Viehbacher, President and Chief Executive O

    7/15/26 8:15:00 AM ET
    $BIIB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APLS
    $BFAM
    $BIIB
    $RELY
    Financials

    Live finance-specific insights

    View All

    Remitly to Report Second Quarter Financial Results on August 5, 2026

    SEATTLE, July 22, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly" or the "Company"), a trusted provider of financial services that transcend borders, today announced that it will report second quarter financial results after the market closes on Wednesday, August 5, 2026. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly Second Quarter Financial Results Conference Call and Webcast Information:When: Wednesday, August 5th, 20

    7/22/26 4:05:00 PM ET
    $RELY
    Real Estate

    Bright Horizons Family Solutions Announces Date of Second Quarter 2026 Earnings Release and Conference Call

    Bright Horizons Family Solutions® Inc. (NYSE:BFAM) will release results for the quarter ended June 30, 2026 on Thursday, July 30, 2026, after the stock market closes. Following the release, the Company will host a telephone conference call with investors and analysts at 5:00 p.m. ET to discuss the second quarter 2026, the Company’s updated business outlook, its strategy and results. Interested parties are invited to listen to the conference call by dialing 1-844-539-3703, or for international callers, 1-412-652-1273, and asking for the Bright Horizons Family Solutions conference call, moderated by Chief Executive Officer Stephen Kramer. Replays of the entire call will be available through

    7/16/26 5:45:00 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary

    S&P Global Evolves Market Intelligence Operating Model to Accelerate Agentic Solutions, Platform Capabilities and Innovation; Announces Executive Leadership Changes

    NEW YORK, July 6, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the new Market Intelligence operating model. This evolution is designed to better align the business with changing customer needs and to position the company for growth in an AI-driven market, pairing its unmatched breadth and depth of data and deep domain expertise with more integrated AI-powered tools, workflows and experiences. S&P Global Market Intelligence will be organized into two focused verticals with distinct but complementary areas, Kensho Data & Platforms and Enterprise Solutions, enabling a streamlined and unified approach to help custome

    7/6/26 7:48:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $APLS
    $BFAM
    $BIIB
    $RELY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Apellis Pharmaceuticals Inc.

    SC 13G/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 4:16:13 PM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Apellis Pharmaceuticals Inc.

    SC 13G - Apellis Pharmaceuticals, Inc. (0001492422) (Subject)

    11/22/24 8:47:59 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Bright Horizons Family Solutions Inc.

    SC 13G/A - BRIGHT HORIZONS FAMILY SOLUTIONS INC. (0001437578) (Subject)

    11/14/24 5:56:31 PM ET
    $BFAM
    Other Consumer Services
    Consumer Discretionary